Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells
Life Science Alliance · 2025
DOI: 10.26508/lsa.202402946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Matthias Eudenbach und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Alternative Splicing, Cell Differentiation, Pluripotent Stem Cells. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, José Carreras Leukämie-Stiftung.
Abstract (Originalsprache)
Protein arginine methyltransferase 6 (PRMT6) is a well-characterized epigenetic regulator that methylates histone H3 at arginine 2 (H3R2me2a) in both promoter and enhancer regions, thereby modulating transcriptional initiation. We report here that PRMT6 also regulates gene expression at the post-transcriptional level in the neural pluripotent state and during neuronal differentiation of NT2/D1 cells. PRMT6 knockout causes widespread alternative splicing changes in NT2/D1 cells, most frequently cassette exon alterations. Most of the PRMT6-dependent splicing targets are not transcriptionally affected by the enzyme and regulated in an H3R2me2a-independent manner. However, for a small subset of splicing events, the PRMT6-mediated deposition of H3R2me2a overlaps with the splice site, suggesting a potential dual function in both transcriptional and co-/post-transcriptional regulation. The splicing targets of PRMT6 include ribosomal proteins, splicing factors, and chromatin-modifying enzymes such as PRMT4, DNMT3B, and ASH2L, some of which are associated with differentiation decisions. Taken together, our results in NT2/D1 cells show that PRMT6 exerts predominantly H3R2me2a-independent functions in RNA splicing, which may contribute to pluripotency and neuronal identity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany.
- Buchmann Institute for Molecular Life Sciences (BMLS) and Institute of Molecular Biosciences, Goethe University Frankfurt, Frankfurt, Germany.
- Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany.
- Institute of Biochemistry, Faculty of Biology and Chemistry (FB08), Justus-Liebig-University of Giessen, Giessen, Germany.
- Institute for Molecular Biology and Tumor Research (IMT), Philipps-University Marburg, Marburg, Germany bauer@imt.uni-marburg.de.
ORCID-Profile: Kathi Zarnack, Uta-Maria Bauer
Förderung
- Deutsche Forschungsgemeinschaft
- José Carreras Leukämie-Stiftung
Zitieren
APA
Eudenbach, M., Busam, J., Bouchard, C., Rossbach, O., Zarnack, K., & Bauer, U. M. (2025). Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells. Life Science Alliance. https://doi.org/10.26508/lsa.202402946
Vancouver
Eudenbach M, Busam J, Bouchard C, Rossbach O, Zarnack K, Bauer UM. Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells. Life Science Alliance. 2025. doi:10.26508/lsa.202402946
BibTeX
@article{Eudenbach2025,
author = {Eudenbach, Matthias and Busam, Jonas and Bouchard, Caroline and Rossbach, Oliver and Zarnack, Kathi and Bauer, Uta-Maria},
title = {Assessment of PRMT6-dependent alternative splicing in pluripotent and differentiating NT2/D1 cells},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202402946}
}
EUVIMED